Assessment of the Electrophysiological Effects of Doxorubicin in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes

被引：0
|
作者：
Goineau, S. [1 ]
Hunault, M. [1 ]
Legrand, C. [1 ]
Hayes, E. [1 ]
Froget, G. [1 ]
Castagne, V. [1 ]
机构：
[1] Porsolt SAS, Le Genest St Isle, France
来源：
INTERNATIONAL JOURNAL OF TOXICOLOGY | 2018年 / 37卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P517
引用
收藏
页码：95 / 96
页数：2
相关论文
共 50 条
  • [1] Assessment of Cardiomyocyte Contraction in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Pointon, Amy
    Harmer, Alexander R.
    Dale, Ian L.
    Abi-Gerges, Najah
    Bowes, Joanne
    Pollard, Christopher
    Garside, Helen
    TOXICOLOGICAL SCIENCES, 2015, 144 (02) : 227 - 237
  • [2] MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes
    Chaudhari, Umesh
    Nemade, Harshal
    Gaspar, John Antonydas
    Hescheler, Jurgen
    Hengstler, Jan G.
    Sachinidis, Agapios
    ARCHIVES OF TOXICOLOGY, 2016, 90 (12) : 3087 - 3098
  • [3] MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes
    Umesh Chaudhari
    Harshal Nemade
    John Antonydas Gaspar
    Jürgen Hescheler
    Jan G. Hengstler
    Agapios Sachinidis
    Archives of Toxicology, 2016, 90 : 3087 - 3098
  • [4] Electrophysiological Changes of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes during Acute Hypoxia and Reoxygenation
    Hakli, Martta
    Kreutzer, Joose
    Maki, Antti-Juhana
    Valimaki, Hannu
    Cherian, Reeja Maria
    Kallio, Pasi
    Aalto-Setala, Katriina
    Pekkanen-Mattila, Mari
    STEM CELLS INTERNATIONAL, 2022, 2022
  • [5] Cardiac proarrhythmic risk assessment using human-induced pluripotent stem cell-derived cardiomyocytes
    Albert, Verena
    Jahic, Mirza
    Servant, Nicole
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2023, 123
  • [6] Assessment of acute and chronic toxicity of doxorubicin in human induced pluripotent stem cell-derived cardiomyocytes
    Louisse, Jochem
    Wust, Rob C. I.
    Pistollato, Francesca
    Palosaari, Taina
    Barilari, Manuela
    Macko, Peter
    Bremer, Susanne
    Prieto, Pilar
    TOXICOLOGY IN VITRO, 2017, 42 : 182 - 190
  • [7] Cyclophosphamide arrhythmogenicitytesting using human-induced pluripotent stem cell-derived cardiomyocytes
    A. D. Podgurskaya
    M. M. Slotvitsky
    V. A. Tsvelaya
    S. R. Frolova
    S. G. Romanova
    V. A. Balashov
    K. I. Agladze
    Scientific Reports, 11
  • [8] Human-induced pluripotent stem cell-derived cardiomyocytes: phenotypic and functional variability
    Koivumaki, J.
    Nikolay, N.
    Tuomainen, T.
    Takalo, J.
    Tavi, P.
    ACTA PHYSIOLOGICA, 2017, 219 : 4 - 4
  • [9] Cyclophosphamide arrhythmogenicitytesting using human-induced pluripotent stem cell-derived cardiomyocytes
    Podgurskaya, A. D.
    Slotvitsky, M. M.
    Tsvelaya, V. A.
    Frolova, S. R.
    Romanova, S. G.
    Balashov, V. A.
    Agladze, K. I.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [10] Electrophysiological Effect of Citreoviridin on Human Induced Pluripotent Stem Cell-derived Cardiomyocytes
    Uchiyama, Yosuke
    Yamazaki, Daiju
    Kobayashi, Naoki
    Kanda, Yasunari
    Sugita-Konishi, Yoshiko
    FOOD HYGIENE AND SAFETY SCIENCE, 2022, 63 (06): : 210 - 217
12345